{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-068055","form_type":"8-K","ticker":"HYPD","cik":"0001682639","company_name":"HYPERION DEFI, INC.","filed_at":"2024-06-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.572542+00:00","generated_at":"2026-06-01T06:33:45.444394+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Eyenovia updates corporate presentation; MicroPine interim readout 4Q 2024, Clobetasol launch 3Q 2024","bullets":["MicroPine Phase 3 CHAPERONE interim DMC review expected 4Q 2024; SAE rate <1 per 1,000 patient-months, all unrelated.","Clobetasol propionate 0.05% launch expected 3Q 2024; projected 3rd-year sales $50M; co-promotion with NovaBay for Avenova.","Optejet Gen-2 FDA meeting planned 3Q 2024 to confirm pathway for drug/device; licensing targets dry eye and glaucoma (>$8.8B market).","MicroPine potential peak US sales >$1B by 2036; net price $200/month, COGS <$20; addresses ~5M high-risk myopic children.","Optecare digital compliance system built into Optejet to track adherence; aims to improve patient outcomes and differentiate."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-068055","json":"https://secwatch.observer/filing/0001104659-24-068055.json","markdown":"https://secwatch.observer/filing/0001104659-24-068055.md","text":"https://secwatch.observer/filing/0001104659-24-068055.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1682639/000110465924068055/0001104659-24-068055-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1682639/000110465924068055/tm2416348d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T06:33:45.444394+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}